Nephrol Dial Transplant (2000) 15: 1493-1503
© 2000 European Renal Association-European Dialysis and Transplant Association
Tony Raine Memorial Lecture
Microvascular disease—the Cinderella of uraemic heart disease
On October 14, 1995, Professor A. Raine (St Bartholomew's Hospital, London) died at the young age of 46 years. He was a fascinating man who combined a rigorous scientific approach with clinical acumen. He excelled in the fields of hypertension research and nephrological research. He was an inspiring investigator whose untimely death is mourned by many colleagues in European nephrology. NDT commemorates the outstanding contributions of our former subject editor in the field of hypertension by a contribution bearing on the major research topic of the late Professor Raine, i.e. the interrelation of kidney and blood pressure. Professor Antony Raine 21.7.49–14.10.95.
1 Department of Pathology, University of Erlangen-Nürnberg and 2 Department of Internal Medicine, University of Heidelberg, Germany
Abstract
It has been known for a long time that atherosclerosis, particularly plaques in the epicardiac coronary conduit arteries, are more frequent in patients with chronic renal failure than in non-uraemic patients. It has been only recently, however, that modification of post-stenotic remodelling of cardiac arteries as well as abnormalities of the arterioles and the capillaries in the myocardium of uraemic animals and uraemic patients have been recognized and analysed. These lesions can be dissociated from changes in blood pressure and may be an important cause contributing to reduced ischaemia tolerance and cardiac malfunction (pump failure, arrhythmia) thus predisposing to cardiac death. Recent insights into angiogenesis, particularly adaptive angiogenesis in response to hypoxia, may potentially provide novel approaches to the understanding and management of cardiac microangiopathy in renal failure.
Keywords: uraemia; uraemic cardiomyopathy; coronary heart disease; heart capillaries; myocardial infarction
Notes
Correspondence and offprint requests to: K. Amann, Department of Pathology, Krankenhausstrasse 8–10, D-91054 Erlangen, Germany.
After the first Tony Raine memorial lecture on the occassion of the Annual Meeting of the European Renal Association (ERA/EDTA) Madrid, Spain 5–8 September 1999.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. S. D. Marco, S. Reuter, U. Hillebrand, S. Amler, M. Konig, E. Larger, H. Oberleithner, E. Brand, H. Pavenstadt, and M. Brand The Soluble VEGF Receptor sFlt1 Contributes to Endothelial Dysfunction in CKD J. Am. Soc. Nephrol., October 1, 2009; 20(10): 2235 - 2245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Dasselaar, R. H. J. A. Slart, M. Knip, J. Pruim, R. A. Tio, C. W. McIntyre, P. E. de Jong, and C. F. M. Franssen Haemodialysis is associated with a pronounced fall in myocardial perfusion Nephrol. Dial. Transplant., February 1, 2009; 24(2): 604 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.H. Messerli, G. Mancia, C.R. Conti, A.C. Hewkin, S. Kupfer, A. Champion, R. Kolloch, A. Benetos, C.J. Pepine, K. Nakagawa, et al. Lowering of Blood Pressure--The Lower, the Better?: Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous? Ann Intern Med 144: 884-893, 2006 J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2345 - 2352. [Full Text] [PDF]
|
|
|
|
|
|
E. H. Y. Ie and R. Zietse Evaluation of cardiac function in the dialysis patient--a primer for the non-expert Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1474 - 1481. [Full Text] [PDF]
|
|
|
|
|
|
P Van der Meer, E Lipsic, R. Henning, K Boddeus, J van der Velden, A. Voors, D. van Veldhuisen, W. van Gilst, R. Schoemaker, J. Leemans, et al. Heart Failure after Myocardial Infarction--Benefit beyond Hemoglobin from Erythropoietin: Erythropoietin Induces Neovascularization and Improves Cardiac Function in Rats with Heart Failure after Myocardial Infarction J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3449 - 3454. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Hazelton and C. Hickey Cinderology: the Cinderella of academic medicine Can. Med. Assoc. J., December 7, 2004; 171(12): 1495 - 1496. [Full Text] [PDF]
|
|
|
|
|
|
T. J. Rabelink Cardiovascular risk in patients with renal disease: treating the risk or treating the risk factor? Nephrol. Dial. Transplant., January 1, 2004; 19(1): 23 - 26. [Full Text] [PDF]
|
|
|
|
|
|
R. Dikow and E. Ritz Cardiovascular complications in the diabetic patient with renal disease: an update in 2003 Nephrol. Dial. Transplant., October 1, 2003; 18(10): 1993 - 1998. [Full Text] [PDF]
|
|
|
|
|
|
P. Stenvinkel, R. Pecoits-Filho, and B. Lindholm Coronary Artery Disease in End-Stage Renal Disease: No Longer a Simple Plumbing Problem J. Am. Soc. Nephrol., July 1, 2003; 14(7): 1927 - 1939. [Full Text] [PDF]
|
|
|
|
|
|
K. Amann, C. Ritz, M. Adamczak, and E. Ritz Why is coronary heart disease of uraemic patients so frequent and so devastating? Nephrol. Dial. Transplant., April 1, 2003; 18(4): 631 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. GANESH, A. G. STACK, N. W. LEVIN, T. HULBERT-SHEARON, and F. K. PORT Association of Elevated Serum PO4, Ca PO4 Product, and Parathyroid Hormone with Cardiac Mortality Risk in Chronic Hemodialysis Patients J. Am. Soc. Nephrol., October 1, 2001; 12(10): 2131 - 2138. [Abstract] [Full Text] [PDF]
|
|